Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Balmain

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Cancer Research|August 28, 2003
Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid miceHiroki Nagase, Jian-Hua Mao, Allan Balmain
Cancer Research|August 3, 2005
Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathwayJesus Perez-Losada, Jian-Hua Mao, Allan Balmain
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2003
Novel approaches to identify low-penetrance cancer susceptibility genes using mouse modelsJohn P de Koning, Jian-Hua Mao, Allan Balmain
The Journal of Biological Chemistry|June 1, 2002
High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signalingEleni Psichari, Allan Balmain, David Plows, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2005
Crosstalk between Pten and Ras signaling pathways in tumor developmentMinh D To, Jesus Perez-Losada, Jian-Hua Mao, et al.
Nature|January 19, 2007
Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB miceYuichi Wakabayashi, Jian-Hua Mao, Ken Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
A gain of function TGFB1 polymorphism may be associated with late stage prostate cancerAmanda Ewart-Toland, June M Chan, Jinwei Yuan, et al.
Oncogene|July 12, 2005
p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivoJesus Perez-Losada, Di Wu, Reyno DelRosario, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2014
Identification of Hipk2 as an essential regulator of white fat developmentJonas Sjölund, Facundo G Pelorosso, David A Quigley, et al.
Plos One|February 21, 2012
Allele-specific deletions in mouse tumors identify Fbxw7 as germline modifier of tumor susceptibilityJesus Perez-Losada, Di Wu, Reyno DelRosario, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Cancer Research|August 28, 2003
Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid miceHiroki Nagase, Jian-Hua Mao, Allan Balmain
Cancer Research|August 3, 2005
Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathwayJesus Perez-Losada, Jian-Hua Mao, Allan Balmain
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2003
Novel approaches to identify low-penetrance cancer susceptibility genes using mouse modelsJohn P de Koning, Jian-Hua Mao, Allan Balmain
The Journal of Biological Chemistry|June 1, 2002
High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signalingEleni Psichari, Allan Balmain, David Plows, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2005
Crosstalk between Pten and Ras signaling pathways in tumor developmentMinh D To, Jesus Perez-Losada, Jian-Hua Mao, et al.
Nature|January 19, 2007
Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB miceYuichi Wakabayashi, Jian-Hua Mao, Ken Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
A gain of function TGFB1 polymorphism may be associated with late stage prostate cancerAmanda Ewart-Toland, June M Chan, Jinwei Yuan, et al.
Oncogene|July 12, 2005
p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivoJesus Perez-Losada, Di Wu, Reyno DelRosario, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2014
Identification of Hipk2 as an essential regulator of white fat developmentJonas Sjölund, Facundo G Pelorosso, David A Quigley, et al.
Plos One|February 21, 2012
Allele-specific deletions in mouse tumors identify Fbxw7 as germline modifier of tumor susceptibilityJesus Perez-Losada, Di Wu, Reyno DelRosario, et al.
Pageof 11